Effects of dyskinesias in Parkinson's disease on quality of life and health‐related costs: a prospective European study
暂无分享,去创建一个
P. Vieregge | G. Berdeaux | C. Clarke | B. Khoshnood | M. Ziégler | P Vieregge | B Khoshnood | C E Clarke | M Ziegler | M. Pechevis | C. Deschaseaux-Voinet | M Péchevis | C Deschaseaux-Voinet | G Berdeaux | M. Péchevis
[1] R. Hills,et al. Evaluating drug treatments for Parkinson's disease: how good are the trials? , 2002, BMJ : British Medical Journal.
[2] W. Greiner,et al. The transferability of international economic health-economic results to national study questions , 2000, HEPAC Health Economics in Prevention and Care.
[3] M. Åsberg,et al. A New Depression Scale Designed to be Sensitive to Change , 1979, British Journal of Psychiatry.
[4] W. Gibb,et al. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. , 1988, Journal of neurology, neurosurgery, and psychiatry.
[5] John E. Ware,et al. SF-36 Health Survey. , 1990 .
[6] W. Oertel,et al. Health-Related Quality of Life and Healthcare Utilisation in Patients with Parkinson’s Disease , 2012, PharmacoEconomics.
[7] E. Scholz,et al. The economic impact of Parkinson's disease. An estimation based on a 3-month prospective analysis. , 1998, PharmacoEconomics.
[8] A. Bonnet,et al. [The Unified Parkinson's Disease Rating Scale]. , 2000, Revue neurologique.
[9] A Schrag,et al. The EQ-5D—a generic quality of life measure—is a useful instrument to measure quality of life in patients with Parkinson's disease , 2000, Journal of neurology, neurosurgery, and psychiatry.
[10] S. Thompson,et al. How should cost data in pragmatic randomised trials be analysed? , 2000, BMJ : British Medical Journal.
[11] J. Ware. SF-36 health survey: Manual and interpretation guide , 2003 .
[12] W. Oertel,et al. Costs of drug treatment in Parkinson's disease , 1998, Movement disorders : official journal of the Movement Disorder Society.
[13] R. Fitzpatrick,et al. Self-reported functioning and well-being in patients with Parkinson's disease: comparison of the short-form health survey (SF-36) and the Parkinson's Disease Questionnaire (PDQ-39) , 1995, Age and ageing.
[14] J. Speelman,et al. Quality of life in patients with Parkinson's disease: development of a questionnaire. , 1996, Journal of neurology, neurosurgery, and psychiatry.
[15] Jeremy Holmes,et al. Direct economic impact of Parkinson's disease: A research survey in the United Kingdom , 2003, Movement disorders : official journal of the Movement Disorder Society.
[16] R B Wallace,et al. The health burdens of Parkinson's disease , 1998, Movement disorders : official journal of the Movement Disorder Society.
[17] A. Lang,et al. Utility of an objective dyskinesia rating scale for Parkinson's disease: Inter‐ and intrarater reliability assessment , 1994, Movement disorders : official journal of the Movement Disorder Society.
[18] J. Larsen,et al. Health related quality of life in Parkinson's disease: a prospective longitudinal study , 2000, Journal of neurology, neurosurgery, and psychiatry.
[19] L. Findley,et al. The economic impact of Parkinson's disease. , 2007, Parkinsonism & related disorders.